GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » General and Admin. Expense

SDZNY (Sandoz Group AG) General and Admin. Expense : $0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sandoz Group AG's General and Admin. Expense for the six months ended in Jun. 2024 was $0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 was $0 Mil.

Sandoz Group AG General and Admin. Expense Historical Data

The historical data trend for Sandoz Group AG's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG General and Admin. Expense Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23
General and Admin. Expense
0.02 -

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
General and Admin. Expense - - - -

Sandoz Group AG General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » General and Admin. Expense
Comparable Companies
XSWX:GALD XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XTAE:TEVA NSE:DIVISLAB VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257
Traded in Other Exchanges
SDZXF:USA SDZz:UK 0SAN:UK D8Y0:Germany SDZ:Switzerland
Address
Forum 1, Novartis Campus, Basel, CHE, CH-4056
Website
https://www.sandoz.com
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.

Sandoz Group AG Headlines

From GuruFocus

Sandoz Group AG (SDZNY) (Q2 2024) Earnings Call Transcript Highlights: Strong Biosimilars Growth and Raised Sales Guidance

By GuruFocus Research • 08-09-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Half Year 2024 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 08-09-2024